http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_242f2565d6747e4079621c1813a60148
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Carracedo |
| name | Angel Carracedo |
| given-name | Angel |
| organization-name | Grupo de Medicina Xenomica ‐ Universidad de Santiago de Compostela Centro Nacional de Genotipado ‐ Instituto Carlos III Santiago de Compostela Spain; Grupo de Medicina Xenomica ‐ USC, CIBERER Fundacion Publica Galega de Medicina Xenomica ‐ SERGAS Santiago de Compostela Spain; Center of Excellence in Genomic Medicine Research King Abdulaziz University Jeddah Saudi Arabia The authors’ affiliations are as follows: the Centre for Cancer Genetic Epidemiology, Departments of Public Health and Primary Care (L.D., S. Carvalho, J.A., K.A.P., Q.W., M.K.B., J.D., B.D., N. Mavaddat, K. Michailidou, A.C.A., P.D.P.P., D.F.E.) and Oncology (C.L., P.A.H., C. Baynes, D.M.C., L.F., V.R., M. Shah, P.D.P.P., A.M.D., D.F.E.), University of Cambridge, Cambridge, the Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine (A. Campbell, D.J.P.), and the... Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain; Centro de Investigación en Red de Enfermedades Raras (CIBERER) y Centro Nacional de Genotipado (CEGEN-PRB2), Universidad de Santiago de Compostela, Santiago De Compostela, Spain Fundación Pública Galega de Medicina Xenómica Instituto de Investigación Sanitaria de Santiago (IDIS) Santiago de Compostela Spain; CIBERER‐Instituto de Salud Carlos III, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS) Universidade de Santiago de Compostela Santiago de Compostela Spain Centro Nacional de Genotipado (CEGEN), Universidade de Santiago de Compostela , 15706 Santiago de Compostela, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III , 28029 Madrid, Spain; Instituto de Investigación Sanitaria de Santiago (IDIS) , 15706 Santiago de Compostela, Spain; Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela , 15782 Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica, Sistema Galego de Saúde (SERGAS) , 15706 Santiago de Compostela, Spain Molecular Medicine Unit-INGO (Sergas), University of Santiago de Compostela, Hospital de Conxo, 15706 Santiago de Compostela, Spain Grupo Medicina Xenomica–CIBERER, Fundación Publica Galega de Medicina Xenómica, Santiago de Compostela, Spain and Fundación Publica Galega de Medicina Xenómica, Hospital Clinico Universitario, 15706, Santiago de Compostela, Spain.; Grupo Medicina Xenomica–CIBERER, Universidad de Santiago de Compostela, Spain Fundación Pública de Medicina Xenómica-SERGAS. Grupo de Medicina Xenómica, CIBERER, IDIS, Santiago de Compostela, Spain Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), University of Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica – Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) – SERGAS (Servicio Galega de Saude), Santiago de Compostela, Spain; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia Fundación Pública Galega de Medicina Xenómica (SERGAS)-CIBERER, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia. Genetic Molecular Unit Galician Public Foundation of Genomic Medicine University of Santiago de Compostela Spain Fundacion Galega de Medicina Xenomica, CIBERER (Centro de Investigacio´n Biome´dica en Red Enfermedades Raras), University of Santiago de Compostela, Santiago, Spain; and the Grupo de Medicina Xenómica, Centro en Red de Enfermedades Raras (CIBERER) Universidade de Santiago de Compostela Santiago de Compostela Spain; Fundación Pública Galega de Medicina Xenómica (SERGAS)‐CIBERER Universidad de Santiago de Compostela Santiago de Compostela Spain Grupo de Medicina Genómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica (SERGAS), IDIS, Santiago de Compostela, Spain. Grupo de Medicina Xenomica, Fundación Pública Galega de Medicina Xeómica (SERGAS), CIBERER-CEGEN, Universidade de Santiago de Compostela, Santiago de Compostela, Spain; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia Genomic Medicine Group, University of Santiago De Compostela, Spain Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the; Authors' Affiliations: 1Department of Public Health and Primary Care, University of Cambridge; Department of 2Public Health and Primary Care and 3Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge; 4Faculty of Health, Social Care & Education, Anglia Ruskin University, Cambridge; 5Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton and Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London; 6School of Public Health, Imperial College London, London; and 7Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 8Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut, Egypt; Divisions of 9Psychosocial Research and Epidemiology and 10Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; 11Department for Health Evidence, Radboud University Medical Centre, Nijmegen; 12National Institute for Public Health and the Grupo de Medicina Genómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica (SERGAS), IDIS, Santiago de Compostela. Molecular Medicine Unit, Fundación Pública Galega de Medicina Xenómica, Choupana S/N, Santiago de Compostela 15706, Spain and Genomic Medicine Group-CIBERER, University of Santiago de Compostela, Calle San Fransisco S/N, Santiago de Compostela 15705, Spain Genomic Medicine Group, Santiago de Compostela Clinical Hospital Complex (CHUS), Santiago de Compostela, Spain; Galician Public Foundation of Genomic Medicine, Santiago de Compostela Clinical Hospital Complex (CHUS), Santiago de Compostela, Spain; Center in Network of Rare Diseases (CIBERER), University of Santiago de Compostela, Santiago de Compostela, Spain Genomic Medicine University of Santiago de Compostela IDIS CIBERER Santiago de Compostela Spain Genomic Medicine Group- Galician Foundation of Genomic Medicine (SERGAS), CIBERER, University of Santiago de Compostela, Santiago de Compostela, Spain Grupo de Medicina Xenomica, Centro Nacional de Genotipado (CEGEN-PRB3), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela Santiago de Compostela Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER‐ISCIII), Instituto de Salud Carlos III Madrid Spain; Fundación Pública Galega de Medicina Xenómica, Sistema Galego de Saúde (SERGAS) Santiago de Compostela Santiago de Compostela Spain; Genetics Research Group, Instituto de Investigación Sanitaria de Santiago (IDIS) Santiago de Compostela Spain University of Santiago de Compostela, Santiago de Compostela, Spain Grupo de Medicina Xenomica Centro Nacional de Genotipado – Plataforma de Recursos Biomoleculares y Bioinformaticos – Instituto de Salud Carlos III (CeGen‐PRB2‐ISCIII) Universidade de Santiago de Compostela Santiago de Compostela Spain; Grupo de Medicina Xenomica CIBERER Fundacion Publica Galega de Medicina Xenomica – SERGAS Santiago de Compostela Spain; Center of Excellence in Genomic Medicine Research King Abdulaziz University Jeddah Saudi Arabia Grupo de Medicina Xenomica Universidade de Santiago de Compostela Centro Nacional de Genotipado—Plataforma de Recursos Biomoleculares y Bioinformaticos—Instituto de Salud Carlos III (CeGen‐PRB2‐ISCIII) Santiago de Compostela Spain; Grupo de Medicina Xenomica CIBERER Fundacion Publica Galega de Medicina Xenomica—SERGAS Santiago de Compostela Spain; Center of Excellence in Genomic Medicine Research King Abdulaziz University Jeddah Saudi Arabia Grupo de Medicina Xenomica Universidade de Santiago de Compostela Centro Nacional de Genotipado Plataforma de Recursos Biomoleculares y Bioinformaticos Instituto de Salud Carlos III (CeGen‐PRB2‐ISCIII) Santiago de Compostela Spain; Grupo de Medicina Xenomica‐USC CIBERER Fundacion Publica Galega de Medicina Xenomica‐SERGAS Santiago de Compostela Spain; King Abdulaziz University Center of Excellence in Genomic Medicine Research Jeddah Saudi Arabia Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain Grupo de Medicina Xenómica, Fundación Galega de Medicina Xenómica (SERGAS) and CIBERER, Universidade de Santiago de Compostela, Santiago de Compostela, Spain,; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, KSA, Genomic Medicine Group, IDIS, Galician Foundation of Genomic Medicine‐SERGAS Santiago De Compostela Spain; ISCIII Center for Biomedical Research on Rare Diseases (CIBERER) Madrid Spain; Spanish National Genotyping Center‐University of Santiago De Compostela, Prb2—Institute of Health Carlos III (ISCIII) Madrid Spain Grupo de Medicina Genómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) Universidad de Santiago de Compostela, Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica (SERGAS), IDIS, Santiago de Compostela Institute of Legal Medicine, Faculty of Medicine, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain. Fundación Publica Galega de Medicina Xenómica Universidad de Santiago de Compostela, Santiago de Compostela Spain Instituto de Medicina Legal, Universidade de Santiago de Compostela Fundación Pública Galega de Medicina Xenómica, SERGAS, Santiago de Compostela Spain; Grupo de Medicina Xenómica, CIBERER Universidade de Santiago de Compostela, Santiago de Compostela Spain; Center of Excellence in Genomic Medicine Research (CEGMR) King Abdulaziz University Jeddah Saudi Arabia Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS), Spain Forensic Genetics Unit Institute of Forensic Science Genomic Medicine Group University of Santiago de Compostela Santiago de Compostela Spain; Center of Excellence in Genomic Medicine Research King Abdulaziz University Jeddah KSA Genomic Medicine Group, Galician Foundation of Genomic Medicine, Servicio Galego de Saude (SERGAS) Instituto de Investigación Sanitaria de Santiago (IDIS) Santiago de Compostela Spain; National Genotyping Center‐Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) University of Santiago de Compostela Galicia Spain; Center of Excellence in Genomic Medicine Research King Abdulaziz University Jeddah Kingdom of Saudi Arabia Fundación Publica Galega de Medicina Xenómica, Universidad de Santiago de Compostela, Santiago de Compostela, Spain Universidad de Santiago de Compostela, Spain; Universidade de Santiago de Compostela, Spain King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia Genomic Medicine Group, Fundacion Publica Galega de Medicina Xenomica (FPGMX), Spanish National Genotyping Center (CeGen)-University of Santiago Compostela, CIBERER, Hospital Clínico, Santiago de Compostela, Galicia, Spain Unidad de Medicina Molecular, Fundación Pública Galega de Medicina Xenómica, (FPGMX), Hospital Clínico Universitario, Santiago de Compostela, Spain; Unidad de Xenética, Instituto de Medicina Legal, Facultad de Medicina, Universidad de Santiago de Compostela, Galicia, Spain Grupo de Medicina Xenomica ‐ Universidade de Santiago de Compostela Centro Nacional de Genotipado ‐ Plataforma de Recursos Biomoleculares y Bioinformaticos ‐ Instituto de Salud Carlos III (CeGen‐PRB2‐ISCIII) Santiago de Compostela Spain; Grupo de Medicina Xenomica‐USC, CIBERER Fundacion Publica Galega de Medicina Xenomica ‐ SERGAS Santiago de Compostela Spain; Center of Excellence in Genomic Medicine Research King Abdulaziz University Jeddah Saudi Arabia Authors' Affiliations: 1Galician Public Foundation of Genomic Medicine (FPGMX), CIBERER, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain; 2Gastroenterology Department, Hospital La Fe, Valencia, Spain; 3Gastroenterology Department, Hospital Meixoeiro, Vigo, Galicia, Spain; 4Gastroenterology Department, Hospital del Mar, Barcelona, Catalonia, Spain; 5Unidad de Gastroenterología, Hospital General Universitario de Alicante, Alicante, Spain; 6Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, Illinois; and 7Gastroenterology Department, Hospital Clínic, CIBEREHD, IDIBAPS, Catalonia, Barcelona, Spain University of Santiago de Compostela, 15705 Santiago de Compostela, Spain; Galician Public Foundation of Genomic Medicine (FPGMX), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia, Spain |
Incoming Links
Total number of triples: 370.